Reduce excess inflammation and swelling angiogenesis, where it stimulates new blood, blood vessel formation, more oxygen and nutrients to damage tissue
Follow-up B12 injections would only be arranged post specific scenarios
Like Methionine, obesity and insulin resistance are thought to be strong activators of mTOR
This triple mechanism distinguishes it from dual-agonist peptides like tirzepatide (GLP-1/GIP) and single-agonist compounds like semaglutide (GLP-1 only), making it the most broadly acting incretin-class compound currently under clinical investigation
Yet, in wellness forums, biohacking communities, and even some clinical settings, these two compounds are routinely lumped together, as if "peptide" were a monolithic category the way "vitamin" or "supplement" might be